CCC, Evidence Partners Announce Delivery Collaboration
Copyright Clearance Center and Evidence Partners are joining forces to offer integrated document delivery through CCC's cloud-based RightFind solution within [...]
Denmark Adopting QALY System for Hospital Drugs
Denmark is shifting to a new evaluation system for hospital drugs based on the quality-adjusted life year (QALY), according to [...]
MCRA Taps McDermott to Head RHEMA Division
Clinical research organization MCRA recently welcomed John McDermott as the senior director of its Reimbursement, Health Economics, and Market Access [...]
CVS Caremark Plan Looks to Nix Costs for Diabetes Drugs
CVS Caremark's newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging [...]
MM&M Set to Release Pharma Marketing Trends in March
MM&M announced it would release its flagship report on marketing in the pharmaceutical industry in March. "The proprietary survey of [...]
New Guidance Enables States to Convert Medicaid Funding into Block Grant
A new initiative rolled out earlier this week by Centers for Medicare and Medicaid Services (CMS) aims to let states [...]
NICE Rejects Coverage of J&J’s Spravato
The U.K.'s National Institute for Health and Care Excellence (NICE) earlier this week rejected coverage of Johnson & Johnson's heavily-criticized [...]
ICER Hosts Meeting on Migraine Treatments
The Institute for Clinical and Economic Review (ICER) hosted a public meeting last week to discuss new treatments for migraines. [...]
Podcast Highlights MS Drug Prices, Football Injuries
A recent Neurology Podcast features a discussion with Dr. Daniel Hartung about his study on drug prices for multiple sclerosis. [...]
Report Puts Spotlight on Pharma Transparency
FirstWord Pharma in its "Pricing Transparency in Pharma" report explores the rising demand for increased transparency. The report highlights 10 [...]
Pearson: Patient Engagement is Key to Fixing ‘Broken’ System
The key first step to fixing the "broken" U.S. health care system is to overhaul how organizations engage with patients, [...]
Patient-Preference Data in Medical Devices to Take Center Stage at ISPOR-FDA Summit
An upcoming summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in conjunction with the Food and [...]
PhRMA Announces HEOR Funding Opportunities
The PhRMA Foundation announced it is accepting applications for up to $100,000 in fellowships and grants for health outcomes research. [...]
Biogen, UPMC Health Plan Contract Links PROs to Drug Reimbursement for Multiple Sclerosis
Biogen and UPMC Health Plan have signed off on a value-based contract that would link reimbursement to patient-reported outcomes for [...]
IQWiG: Patient Registry Data can be Used in Benefit Assessments
High-quality data from patient registries can be utilized for added benefit assessments for new drugs, the Institute for Quality and [...]
Pink Sheet Report Looks at Influence of NHS England, NICE
A recent analysis by The Pink Sheet dives into the influence of two drug pricing forces in the U.K.: the [...]
Survey Finds Increasing Interest in Patient-Reported Data from Outcomes-Based Contracts
A new survey conducted by Avalere Health suggests rising interest among payers to generate patient-reported data through outcomes-based contracts, according [...]
Report: Gene Therapies Could Add $45B to Health Costs
A new report from CVS Health suggests gene therapies could add an additional $45 billion to health care costs over [...]
ISPOR Conducting Survey on Current Understanding of COA Terms
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Clinical Outcome Assessment (COA) Special Interest Group is seeking member input [...]
FDA Pushes Back Deadline for Feedback on Drug Effectiveness Evidence Guide
The Food and Drug Administration (FDA) announced last week that it had extended the deadline for input on its draft [...]
GMI: HEOR Market to Hit $1.7B by 2026
The health economics and outcomes research (HEOR) market will exceed $1.7 billion by 2026, Global Market Insights suggests in a [...]
A Look at California’s Plan to Make Generic Drugs
A recent report by The Sacramento Bee takes an in-depth look at California's plan to manufacture its own generic drugs [...]
SDOH Vendors Look to Build Pathways to Key Resources
New specialized vendors are taking action with social determinants of health by developing new software solutions that aim to bridge [...]
Dems Pivot to Insulin, Illinois Caps Insulin Prices
Democratic presidential candidates during a campaign stop in Iowa made clear their frustration over U.S. insulin prices, STAT reports. During [...]
NPC’s Leonard Outlines ‘Wish List’ for Health Sector
National Pharmaceutical Council President and CEO Dan Leonard in an article published on Chain Drug Review outlines his wish list [...]